Sonoma Pharmaceuticals (NASDAQ:SNOA) stock is getting a boost on Tuesday after the company revealed positive news from the U.S. Environmental Protection Agency (EPA).
The big news sending SNOA stock higher today is the EPA approving Nanocyn. This is the pharmaceutical company’s hospital-grade disinfectant. It is designed to treat hard surfaces, which makes it ideal for use in “hospitals, schools, mass transit, and care facilities.”
Sonoma Pharmaceuticals manufactures Nanocyn and it’s made with patented technology from MicroSafe. The two worked together to have the product approved by the EPA following its success in other countries.
According to Sonoma Pharmaceuticals, Nanocyn sports a 30-second kill time that will see it removing bacteria from non-porous hard surfaces. It’s also worth noting that the Australian Register of Therapeutic Goods recognized it for use against Covid-19 in 2020.
Amy Trombly, CEO of Sonoma Pharmaceuticals, said this about the Nanocyn news today.
‘We are excited to bring our successful partnership with MicroSafe Group to the United States. We believe Nanocyn hospital-grade disinfectant has countless applications due to its efficacy and safety profile, and we are eager to play a role to help curb the spread of infectious disease here in the United States and globally.”
SNOA stock is experiencing heavy trading alongside today’s news. As of this writing, more than 50 million shares of the stock have been traded. That’s well above its daily average trading volume of around 143,000 shares.
SNOA stock is up 27.8% as of Tuesday afternoon.
Investors on the lookout for more stock market news will want to stick around!
InvestorPlace has all the latest stock news that traders need to know about for Tuesday. Among that is what’s happening with shares of IonQ (NYSE:IONQ) stock, Chegg (NYSE:CHGG) stock, and Harbor Custom Development (NASDAQ:HCDI) stock today. You can learn all about these topics by checking out the links below!
More Tuesday Stock Market News
On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com Publishing Guidelines.
With only the rarest exceptions, InvestorPlace does not publish commentary about companies that have a market cap of less than $100 million or trade less than 100,000 shares each day. That’s because these “penny stocks” are frequently the playground for scam artists and market manipulators. If we ever do publish commentary on a low-volume stock that may be affected by our commentary, we demand that InvestorPlace.com’s writers disclose this fact and warn readers of the risks.
Read More: Penny Stocks — How to Profit Without Getting Scammed